Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines

Fig. 6

E-cad protein levels are not significantly changed in the carcinoma cell lines derived from metastatic tumors compared to the carcinoma cell lines derived from primary tumors. A, E-cad protein levels are not significantly different in the carcinoma cell lines derived from metastatic tumors compared to the carcinoma cell lines derived from primary tumors of pancreatic (11 metastatic (M); 7 primary (P)), lung (49 M; 30 P), ovarian (8 M; 9 P), colorectal (9 M; 17 P), head/neck (4 M; 6 P), endometrial (2 M; 11 P), and breast (16 M; 14 P) carcinomas. B, The E-cad level in the combined metastatic carcinoma cell lines was not statistically different from the level in the combined primary tumor cell lines (101 M; 117 P)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us